Long-term exposure to PM2.5 air pollution from vehicles and power plants may raise the risk of dementia by affecting the ...

A study finds over 35% of AI responses on substance use contain stigmatizing language-yet targeted prompts can reduce bias in ...

Ketamine’s rapid antidepressant effects may involve the brain’s opioid system, offering insight into how it works and paving ...

In fact, it's not even close to rare. Right here in Washington State, over 165,000 children are estimated to be living with the effects of Fetal Alcohol Spectrum Disorders (FASD) or Prenatal Substance ...

PFAS exposure has been linked to genetic changes that may contribute to the development of cancer, neurological disorders, and autoimmune conditions.

MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the trial evaluating ENLIGHTEN®, a first-of-its-kind blood test, registered with ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

50% compression of full target–disease–drug analysis workflows Rare disease landscape mapping shortened from 12 weeks to under 3 ...

SkyQuest Technology Consulting published a report, titled, Remote Patient Monitoring Market - Global Opportunity Analysis and Indust ...

This report provides a thorough overview of the global market for thyroid gland disorder diagnostics and treatments. It segments the market by disease type (such as hypothyroidism ...

Researchers at the University of Colorado Anschutz Medical Campus , Montefiore Einstein Comprehensive Cancer Center (MECCC), and Utrecht University have found the first direct ...